The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Short Bowel Syndrome Drugs Market Research Report 2025
Synopsis
The global Short Bowel Syndrome Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Short Bowel Syndrome Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Bowel Syndrome Drugs.
Report Scope
The Short Bowel Syndrome Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Short Bowel Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short Bowel Syndrome Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
Emmaus Medical
Merck
Takeda
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
GLyPharma Therapeutic
Sancilio Pharmaceuticals
Zealand Pharma
Segment by Type
Oral Short Bowel Syndrome Drugs
Tablet Short Bowel Syndrome Drugs
Segment by Sale Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Short Bowel Syndrome Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Short Bowel Syndrome Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Short Bowel Syndrome Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Short Bowel Syndrome Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Bowel Syndrome Drugs.
Report Scope
The Short Bowel Syndrome Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Short Bowel Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short Bowel Syndrome Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
Emmaus Medical
Merck
Takeda
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
GLyPharma Therapeutic
Sancilio Pharmaceuticals
Zealand Pharma
Segment by Type
Oral Short Bowel Syndrome Drugs
Tablet Short Bowel Syndrome Drugs
Segment by Sale Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Short Bowel Syndrome Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Short Bowel Syndrome Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Short Bowel Syndrome Drugs Market Overview
1.1 Product Overview and Scope of Short Bowel Syndrome Drugs
1.2 Short Bowel Syndrome Drugs Segment by Type
1.2.1 Global Short Bowel Syndrome Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral Short Bowel Syndrome Drugs
1.2.3 Tablet Short Bowel Syndrome Drugs
1.3 Short Bowel Syndrome Drugs Segment by Sale Channel
1.3.1 Global Short Bowel Syndrome Drugs Market Value by Sale Channel: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Short Bowel Syndrome Drugs Market Size Estimates and Forecasts
1.4.1 Global Short Bowel Syndrome Drugs Revenue 2019-2030
1.4.2 Global Short Bowel Syndrome Drugs Sales 2019-2030
1.4.3 Global Short Bowel Syndrome Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Short Bowel Syndrome Drugs Market Competition by Manufacturers
2.1 Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Short Bowel Syndrome Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Short Bowel Syndrome Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Short Bowel Syndrome Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Short Bowel Syndrome Drugs, Product Type & Application
2.7 Short Bowel Syndrome Drugs Market Competitive Situation and Trends
2.7.1 Short Bowel Syndrome Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Short Bowel Syndrome Drugs Players Market Share by Revenue
2.7.3 Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Short Bowel Syndrome Drugs Retrospective Market Scenario by Region
3.1 Global Short Bowel Syndrome Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Short Bowel Syndrome Drugs Global Short Bowel Syndrome Drugs Sales by Region: 2019-2030
3.2.1 Global Short Bowel Syndrome Drugs Sales by Region: 2019-2024
3.2.2 Global Short Bowel Syndrome Drugs Sales by Region: 2025-2030
3.3 Global Short Bowel Syndrome Drugs Global Short Bowel Syndrome Drugs Revenue by Region: 2019-2030
3.3.1 Global Short Bowel Syndrome Drugs Revenue by Region: 2019-2024
3.3.2 Global Short Bowel Syndrome Drugs Revenue by Region: 2025-2030
3.4 North America Short Bowel Syndrome Drugs Market Facts & Figures by Country
3.4.1 North America Short Bowel Syndrome Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Short Bowel Syndrome Drugs Sales by Country (2019-2030)
3.4.3 North America Short Bowel Syndrome Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Short Bowel Syndrome Drugs Market Facts & Figures by Country
3.5.1 Europe Short Bowel Syndrome Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Short Bowel Syndrome Drugs Sales by Country (2019-2030)
3.5.3 Europe Short Bowel Syndrome Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Short Bowel Syndrome Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Short Bowel Syndrome Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Short Bowel Syndrome Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Short Bowel Syndrome Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Short Bowel Syndrome Drugs Market Facts & Figures by Country
3.7.1 Latin America Short Bowel Syndrome Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Short Bowel Syndrome Drugs Sales by Country (2019-2030)
3.7.3 Latin America Short Bowel Syndrome Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Short Bowel Syndrome Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Short Bowel Syndrome Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Short Bowel Syndrome Drugs Sales by Type (2019-2030)
4.1.1 Global Short Bowel Syndrome Drugs Sales by Type (2019-2024)
4.1.2 Global Short Bowel Syndrome Drugs Sales by Type (2025-2030)
4.1.3 Global Short Bowel Syndrome Drugs Sales Market Share by Type (2019-2030)
4.2 Global Short Bowel Syndrome Drugs Revenue by Type (2019-2030)
4.2.1 Global Short Bowel Syndrome Drugs Revenue by Type (2019-2024)
4.2.2 Global Short Bowel Syndrome Drugs Revenue by Type (2025-2030)
4.2.3 Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Short Bowel Syndrome Drugs Price by Type (2019-2030)
5 Segment by Sale Channel
5.1 Global Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2030)
5.1.1 Global Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2024)
5.1.2 Global Short Bowel Syndrome Drugs Sales by Sale Channel (2025-2030)
5.1.3 Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2019-2030)
5.2 Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2030)
5.2.1 Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2024)
5.2.2 Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2025-2030)
5.2.3 Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2019-2030)
5.3 Global Short Bowel Syndrome Drugs Price by Sale Channel (2019-2030)
6 Key Companies Profiled
6.1 Emmaus Medical
6.1.1 Emmaus Medical Corporation Information
6.1.2 Emmaus Medical Description and Business Overview
6.1.3 Emmaus Medical Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Emmaus Medical Short Bowel Syndrome Drugs Product Portfolio
6.1.5 Emmaus Medical Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Short Bowel Syndrome Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Short Bowel Syndrome Drugs Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Ardelyx
6.4.1 Ardelyx Corporation Information
6.4.2 Ardelyx Description and Business Overview
6.4.3 Ardelyx Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ardelyx Short Bowel Syndrome Drugs Product Portfolio
6.4.5 Ardelyx Recent Developments/Updates
6.5 Naia Pharmaceuticals
6.5.1 Naia Pharmaceuticals Corporation Information
6.5.2 Naia Pharmaceuticals Description and Business Overview
6.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Portfolio
6.5.5 Naia Pharmaceuticals Recent Developments/Updates
6.6 Nutrinia
6.6.1 Nutrinia Corporation Information
6.6.2 Nutrinia Description and Business Overview
6.6.3 Nutrinia Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nutrinia Short Bowel Syndrome Drugs Product Portfolio
6.6.5 Nutrinia Recent Developments/Updates
6.7 OxThera
6.6.1 OxThera Corporation Information
6.6.2 OxThera Description and Business Overview
6.6.3 OxThera Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 OxThera Short Bowel Syndrome Drugs Product Portfolio
6.7.5 OxThera Recent Developments/Updates
6.8 GLyPharma Therapeutic
6.8.1 GLyPharma Therapeutic Corporation Information
6.8.2 GLyPharma Therapeutic Description and Business Overview
6.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Portfolio
6.8.5 GLyPharma Therapeutic Recent Developments/Updates
6.9 Sancilio Pharmaceuticals
6.9.1 Sancilio Pharmaceuticals Corporation Information
6.9.2 Sancilio Pharmaceuticals Description and Business Overview
6.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Portfolio
6.9.5 Sancilio Pharmaceuticals Recent Developments/Updates
6.10 Zealand Pharma
6.10.1 Zealand Pharma Corporation Information
6.10.2 Zealand Pharma Description and Business Overview
6.10.3 Zealand Pharma Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zealand Pharma Short Bowel Syndrome Drugs Product Portfolio
6.10.5 Zealand Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Short Bowel Syndrome Drugs Industry Chain Analysis
7.2 Short Bowel Syndrome Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Short Bowel Syndrome Drugs Production Mode & Process
7.4 Short Bowel Syndrome Drugs Sales and Marketing
7.4.1 Short Bowel Syndrome Drugs Sales Channels
7.4.2 Short Bowel Syndrome Drugs Distributors
7.5 Short Bowel Syndrome Drugs Customers
8 Short Bowel Syndrome Drugs Market Dynamics
8.1 Short Bowel Syndrome Drugs Industry Trends
8.2 Short Bowel Syndrome Drugs Market Drivers
8.3 Short Bowel Syndrome Drugs Market Challenges
8.4 Short Bowel Syndrome Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
